Visit Website →
← Back to blog

Preventive Care ROI Myths: What the Evidence Shows

October 26, 2026
Preventive Care ROI Myths: What the Evidence Shows

Preventive care does not automatically save money, and it does not automatically waste it. Whether a program pays back depends on the service, the people who receive it, the time horizon and how you count. For employers, that means the useful question is not "does prevention pay?" but "which prevention pays, for which employees, and by when?"

Below are seven myths we hear from CFOs, HR leaders and benefit advisors, each tested against published research, followed by a practical way to estimate and track results without overstating them.

Hadaco
Measure Prevention With Greater Clarity
Hadaco complements existing health plans with evidence-based programs and quarterly reporting to help employers track claims costs and employee engagement.
Explore Hadaco’s approach

TL;DR

  • Prevention is not a blanket money-saver. Some services cut costs, many improve health at a fair price, and some cost more than they return.
  • Targeting matters more than volume. Programs aimed at employees with chronic conditions have the strongest financial evidence; broad lifestyle programs mostly do not move claims.
  • Published ROI figures are illustrations, not guarantees. Study methods, time horizons and comparison groups change the answer.
  • Measure your own claims and engagement data, report them on a schedule, and keep health outcomes and dollar returns as separate scorecards.

Table of Contents

What "ROI" means for an employer

In the research literature, return on investment describes economic benefits relative to the money put in. It can be expressed as a ratio of profits to investment or as a payback period, and it can include nonmonetary indicators such as fewer lost hours or higher productivity.

That definition is broader than what most finance teams mean. A CFO usually wants one number: dollars of claims avoided per dollar spent. An HR leader may care about absenteeism, retention and engagement as well. Both are legitimate, but they are different measures, and mixing them is the root of several myths below.

It helps to settle at the start which of these you are buying. We cover the full measurement toolkit in our guide to corporate wellness ROI for HR leaders.

Myth 1: Preventive care always pays for itself

This is the most repeated claim and the least supported. A 2025 analysis in JAMA Health Forum concludes that prevention does not universally save money: the result depends on what the intervention costs, what downstream care it averts, and how many people must be treated to avert one event.

The economist Joseph Newhouse frames preventive measures as something closer to insurance. In his National Bureau of Economic Research paper, he notes that most medical prevention improves expected health but does not save money: you pay certain costs now for an uncertain payoff later.

A 2009 review by Neumann and Cohen adds two reasons. Preventive costs are often offset by screening and treatment expenses, or by the cost of care for people who live longer because prevention worked. Only a few services, such as childhood immunizations and certain adult counseling, are widely regarded as cost-saving.

What to do instead: treat each program as its own investment case. Ask what it costs per person reached, what event it prevents, how often that event occurs in your population and what that event costs your plan.

Myth 2: If it does not save money, it is not worth doing

The opposite mistake is just as common. The 2008 New England Journal of Medicine article by Cohen, Neumann and Weinstein points out that measures that do not save money can still be good value when they deliver large health gains relative to their cost.

Baicker and Chandra make a similar argument in JAMA Health Forum: focusing only on whether a program saves money is often a mistake, and programs should be judged on whether they improve health enough for what they cost. Neumann and Cohen suggest the policy goal should be high-value care rather than cost-saving care.

For an employer, this is a budget-setting question. A cancer screening benefit that is cost-neutral but catches disease earlier may be worth funding for people reasons. You just should not put it in the savings column of your business case.

Myth 3: Wellness programs and preventive care are the same thing

They overlap, but the evidence differs sharply by program type. The RAND Corporation analyzed a Fortune 100 employer's program and found that disease management accounted for 87% of the total savings of $30 per member per month, while lifestyle management contributed only slightly to financial returns. RAND's conclusion: lifestyle management may improve health and reduce absenteeism without consistently returning money, and employers seeking ROI should focus on employees with chronic disease.

RAND savings share by program type

The 2025 JAMA Health Forum analysis points the same way, noting that many lifestyle and behavioral health promotion programs have not shown significant effects on costs or clinical outcomes in randomized trials.

So "we have a wellness program" says almost nothing about financial return. A step challenge, a gym discount and a structured diabetes management program are three different investments with three different evidence bases.

Myth 4: The ROI studies settle the question

The studies are useful, and they disagree. Consider two recent systematic reviews of workplace prevention:

ReviewScopeHeadline finding
European Journal of Public Health, 2023138 workplace interventions78 (56.5%) had positive ROI, 12 (8.7%) negative, 35 (25.4%) undetermined
BMC Public Health, 2026112 studies, 2003 to 202489% reported positive cost-benefit ratios; ergonomic interventions had the highest median ratio at 5.2:1

Both are real, and neither means your program will return a fixed multiple. The authors of the 2023 review cautioned that ROI results should be read as illustrations rather than absolute proof because of limits in study methods.

Three things explain the spread. First, the interventions differ: an ergonomic fix for a physical injury risk is not a smoking cessation program. Second, published studies skew toward programs someone chose to evaluate and report. Third, the settings vary by country, industry and workforce. When a vendor quotes a headline multiple, ask which intervention, which population, what comparison group and over what period.

Myth 4: The ROI studies settle the question — overview diagram

Myth 5: Everyone should get every screening

The 2008 NEJM analysis explains why this fails financially: efficiency in prevention often depends on targeting high-risk groups. Used on low-risk people, a measure can cost more than it saves because it fails to prevent enough cases to offset the cost of screening everyone.

The GAO reached a similar conclusion in 2014, reporting that whether preventive services save money depends on factors such as the targeted population, for example children versus high-risk adults, and on assumptions about how effective the service is.

For employers, the practical translation is claims-informed targeting. If your data show a cluster of employees with uncontrolled hypertension or diabetes, outreach to them is a different investment than a company-wide push. We walk through that approach in our piece on using claims data to guide wellness spending.

Myth 6: Disease management is the same as prevention, so it always works

Disease management, which supports people who already have a condition, is where the strongest cost evidence sits. RAND's work points to heart disease, diabetes and congestive heart failure as areas with stronger evidence of reduced spending.

But "stronger" is not "universal". A 2005 review of 44 studies found positive ROI for congestive heart failure and multiple-illness programs, mixed results for asthma, and depression programs that cost more in medical expenses than they saved. That does not make depression care a bad idea. It means the case for it rests on health, function and productivity, not on claims reductions alone.

This is also why a program that spans chronic disease, preventive care, mental health and engagement should report each stream separately, so a strong result in one area does not hide a weak one in another.

Myth 7: A one-year payback is the standard to hold every program to

Time horizon changes the verdict. The U.S. Department of Health and Human Services (ASPE) notes that the horizon chosen for an economic model significantly affects results, because short horizons can miss long-term financial benefits. ASPE also flags that results are highly sensitive to the comparator, meaning what you assume would have happened without the program.

A RAND Europe report on workplace prevention adds that benefits from things like smoking cessation or blood pressure management may take years to accrue, which calls for inflation and discounting adjustments.

There is a second timing problem unique to employers: turnover. If an employee leaves before the benefit arrives, the savings accrue to another plan. That argues for putting near-term, claims-visible conditions first in a payback model and treating long-horizon benefits as upside rather than the base case.

How to estimate the budget impact without fooling yourself

A defensible estimate is more modest than a vendor deck and more persuasive to a CFO. Use this sequence:

  1. Pick the goal. RAND advises employers to clarify whether they want ROI or improved health and productivity, since lifestyle programs fit the second goal and ROI-seeking employers should target employees with chronic disease.
  2. Find the cost drivers. Use your own claims to identify the conditions and cohorts that drive spending. Averages from other employers are a starting point only.
  3. Estimate reach honestly. Savings apply to people who actually participate. Multiply the per-person effect by realistic enrollment and engagement, not by headcount.
  4. Choose a comparator. Define what would have happened without the program: a matched group, your prior-year trend or a pre-period baseline. Write down the assumption.
  5. Set the horizon. Show a 12-month view and a longer one, with discounting for the longer one.
  6. Separate the scorecards. Track dollars (claims, program fees) apart from health outcomes (control rates, screening completion) and workforce measures (engagement, absence, retention).

Most organizations skip step 6 and the measurement behind it. A 2017 RAND Europe survey found that only about 17% of UK companies measured ROI on health initiatives and just 3% measured it in financial terms. That is a UK figure, but it matches what many U.S. benefit teams tell us: nobody is quite sure what the program returned.

Plan design matters too. How your plan is funded affects who captures savings and what you can measure, which we cover in self-funded versus fully insured wellness.

Our perspective: pay for outcomes you can verify

We built Hadaco around a simple view: the honest answer to "does preventive care save money?" is "sometimes, and you can find out where." That is why we do not promise that every wellness dollar comes back. We aim programs at the places where the evidence is strongest, such as chronic disease, preventive care that fits your population, mental health and engagement, and we let your own numbers decide whether it worked.

Three principles follow from that.

Complement the plan, do not replace it. Employees already have benefits they understand. Our programs work alongside existing plans rather than disrupting them, so there is no migration project standing between you and results.

Make the estimate visible before you commit. Our savings estimator lets you see the assumptions behind a projected figure. Across companies in their first year, we see an average savings of $451 per employee. That is an average, not a promise for your workforce, which is why we encourage you to run your own numbers rather than rely on ours.

Tie the fee to the result. Our model carries no upfront fees, and our compensation is contingent on demonstrated healthcare savings and engagement outcomes. If prevention does not show up in your claims, we should not be paid as though it did. Quarterly reporting keeps both sides looking at the same data.

The literature says the savings case is real for some interventions and absent for others. An employer should want a partner who is willing to be measured on exactly that line.

— Gene

Where Hadaco fits

If you are weighing a population health program and want to see what the evidence-based approach could mean for your claims, Hadaco's employer programs are built for mid-sized and large employers and for the benefit advisors who serve them. You can start with the savings estimator and a consultation, and there are no upfront fees. For a broader look at the economics, read how wellness programs reduce employee healthcare costs and what a self-funded employer can expect to save.

FAQ

Does preventive care save money?

Sometimes. Some services, such as childhood immunizations, are widely regarded as cost-saving, while many others improve health at reasonable cost without reducing spending. The 2008 NEJM analysis concludes that the answer depends on the specific intervention, the population targeted and how often the service is delivered.

What is a realistic ROI for a workplace prevention program?

Published results range widely. In the 2023 systematic review, just over half of 138 interventions showed positive ROI and a notable share were undetermined or negative. Treat any single multiple as an illustration, and build your own estimate from your claims data, participation rates and time horizon.

Which employee health programs have the strongest financial evidence?

Programs for people who already have costly chronic conditions, such as heart disease, diabetes and congestive heart failure, have the strongest evidence in RAND's analysis. General lifestyle programs tend to improve health and absenteeism but do not consistently return money.

How long does it take to see savings?

It depends on the condition. Claims-visible chronic disease management can show up within a year, while benefits from things like blood pressure control or smoking cessation may take years. Model both a short and a long horizon, and report them separately.

How should we measure results without overstating them?

Define a comparator before the program starts, count only participants, and keep financial results separate from health and engagement outcomes. Review them on a fixed schedule, quarterly is common, so trends are visible and assumptions can be corrected early.

Sources